Prudential PLC decreased its position in CME Group Inc. (NASDAQ:CME) by 7.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,980 shares of the financial services provider’s stock after selling 300 shares during the quarter. Prudential PLC’s holdings in CME Group were worth $499,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Fiduciary Trust Co. acquired a new position in shares of CME Group in the second quarter valued at approximately $105,000. Parallel Advisors LLC grew its position in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after purchasing an additional 43 shares during the last quarter. Whittier Trust Co. grew its position in shares of CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 27 shares during the last quarter. People s United Financial Inc. grew its position in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares during the last quarter. Finally, Mckinley Capital Management LLC Delaware acquired a new position in shares of CME Group in the second quarter valued at approximately $150,000. 82.64% of the stock is currently owned by institutional investors.
CME has been the topic of a number of analyst reports. Royal Bank Of Canada increased their price target on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 20th. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a research report on Friday, June 23rd. Deutsche Bank AG reduced their price target on CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a research report on Tuesday, July 4th. Jefferies Group LLC reissued a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. Finally, Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $135.89.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. The firm had revenue of $925.00 million during the quarter, compared to analyst estimates of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 EPS. Analysts forecast that CME Group Inc. will post $4.81 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Monday, September 25th. Stockholders of record on Friday, September 8th were given a dividend of $0.66 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.92%. CME Group’s dividend payout ratio (DPR) is currently 53.99%.
In related news, insider Hilda Harris Piell sold 1,350 shares of the company’s stock in a transaction on Thursday, October 5th. The shares were sold at an average price of $138.00, for a total value of $186,300.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Dennis Suskind sold 750 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $129.34, for a total transaction of $97,005.00. Following the completion of the transaction, the director now owns 5,059 shares of the company’s stock, valued at $654,331.06. The disclosure for this sale can be found here. Insiders have sold a total of 47,094 shares of company stock valued at $5,896,940 over the last 90 days. Company insiders own 0.57% of the company’s stock.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
What are top analysts saying about CME Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc. and related companies.